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Abstract
This study aimed to assess how female breast cancer survivors (BCS) respond physio-
logically, hematologically, and perceptually to exercise under heat stress compared to 
females with no history of breast cancer (CON). Twenty- one females (9 BCS and 12 
CON [age; 54 ± 7 years, stature; 167 ± 6 cm, body mass; 68.1 ± 7.62 kg, and body fat; 
30.9 ± 3.8%]) completed a warm (25℃, 50% relative humidity, RH) and hot (35℃, 
50%RH) trial in a repeated- measures crossover design. Trials consisted of 30 min of 
rest, 30 min of walking at 4 metabolic equivalents, and a 6- minute walk test (6MWT). 
Physiological measurements (core temperature (Tre), skin temperature (Tskin), heart 
rate (HR), and sweat analysis) and perceptual rating scales (ratings of perceived exer-
tion, thermal sensation [whole body and localized], and thermal comfort) were taken 
at 5- and 10- min intervals throughout, respectively. Venous blood samples were taken 
before and after to assess; IL- 6, IL- 10, CRP, IFN- γ, and TGF- β1. All physiological 
markers were higher during the 35 versus 25℃ trial; Tre (~0.25℃, p = 0.002), Tskin 
(~3.8℃, p < 0.001), HR (~12 beats·min−1, p = 0.023), and whole- body sweat rate 
(~0.4 L·hr−1, p < 0.001), with no difference observed between groups in either condi-
tion (p > 0.05). Both groups covered a greater 6MWT distance in 25 versus 35℃ (by 
~200 m; p = 0.003). Nevertheless, the control group covered more distance than BCS, 
regardless of environmental temperature (by ~400 m, p = 0.03). Thermoregulation 
was not disadvantaged in BCS compared to controls during moderate- intensity ex-
ercise under heat stress. However, self- paced exercise performance was reduced for 
BCS regardless of environmental temperature.
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1 |  INTRODUCTION
Breast cancer accounts for 30% of all new cancer diagnoses, 
equating to one in seven women predicted to develop BC in their 
lifetime (Bray et al., 2018). Although the prevalence of BC rises 
each year, there has been a significant reduction in mortality rate 
in the past two decades, reinforced by survival rates of ~76% in 
the United Kingdom (Cancer Research UK, 2020) and up to 90% 
in the United States (Siegel et al., 2019). Regular physical activ-
ity has been suggested to reduce cancer recurrence by 21%– 35% 
(Cormie et al., 2017), while also improving cardiorespiratory 
fitness, and reducing insulin resistance, adiposity, and chronic 
low- grade inflammation, alongside an improved quality of life, 
without adverse side effects (Speck et al., 2010). Increasing phys-
ical activity is essential for BCS to begin to offset the reduced 
peak oxygen consumption (~20%) (Burnett et al., 2013; Jones 
et al., 2012), increased intermuscular fat (Reding et al., 2019), 
and prevalence of cardiovascular and/or myocardial injury post- 
cancer treatment (Beaudry et al., 2019; Jones et al., 2007), all 
prognostic of increased risk of cardiovascular disease- related all- 
cause mortality and reduced exercise tolerance. However, survey 
and epidemiological data estimate that BCS reduce participa-
tion in physical activity by ~50% within a year post- treatment 
(Littman et al., 2010). Reductions in physical activity are not re-
covered long term, and post- treatment side effects are commonly 
reported as a barrier to exercise in this population, hindering pa-
tient's return to normal life (Fong et al., 2012).
An estimated 93% of BCS report at least one adverse side 
effect 6  months post- diagnosis (Ellegaard et al., 2017), with 
symptoms remaining for at least 6 years in 60% of individu-
als (Schmitz et al., 2012). Negative side effects include, but are 
not limited to; fatigue, chronic low- grade inflammation, cardiac 
toxicity, depression, sleep disturbance, and menopausal/vaso-
motor symptoms (Carpenter, Elam, et al., 2004; Curigliano 
et al., 2010; Schmitz et al., 2012). Hot flashes (HF) and the 
resulting night sweats, indicators of vasomotor symptoms, are 
two of the most impactful symptoms to physical functioning 
and quality of life for BCS (Fisher et al., 2013). The prevalence 
of hot flashes is about 65%, with a third of patients (~30%) re-
porting them as extremely severe (Carpenter et al., 1998; Chang 
et al., 2016; Garcia et al., 2015). It is reported that HFs for BCS 
are more severe and frequent than those associated with natu-
ral menopause (Carpenter, Gilchrist, et al., 2004) and although 
are poorly understood, with majority of the research surround-
ing menopause rather than BCS, are suggestive of an altered 
thermoregulatory control (Charkoudian, 2003). First, there is 
evidence to suggest the thermoneutral zone (between upper 
threshold for sweating and lower for shivering) is reduced to 
0.0℃ in symptomatic women (Freedman & Krell, 1999). On 
the one hand, this can lead to faster onset of heat dissipation 
mechanisms (sweating), which is an advantageous thermo-
regulatory response for those suffering hot flashes. However, 
the increased sweating response can lead to dehydration more 
quickly, which can lead to heat- related illnesses (Coris et al., 
2004). Moreover, hot flashes are believed to be triggered by 
core temperature elevations within this narrowed thermoneutral 
zone in postmenopausal women (Freedman, 2014; Freedman 
et al., 1995; Freedman & Woodward, 1996). Currently, there is 
a paucity of data on the mechanisms underlying hot flashes and 
thermoregulation in both menopausal women and BCS. It is 
reported for BCS to experience thermal discomfort from these 
symptoms (Kokolus et al., 2010), which can be heightened 
during warm weather and via peripheral heating (Freedman, 
1989; Freedman et al., 1992; Kronenberg & Barnard, 1992), 
therefore warranting further investigation in this population.
Physical activity in hot environments and the associated 
increase in heat strain, can trigger the release of pro- and 
anti- inflammatory cytokines (Mündel et al., 2010). These 
immune alterations may be considered as surrogate markers 
of the human physiological response to heat stress (Wright 
et al., 2014). However, to date, previous studies examining 
cytokine responses to exercise in the heat are sparse and pri-
marily limited to the study of younger (Mündel et al., 2010; 
Rhind et al., 2004; Selkirk et al., 2008) or older (Wright et al., 
2012, 2014) males. Consequently, our understanding of how 
breast cancer can alter immunological responses to exercise 
in the heat remain poor, despite a warming climate (Hajat 
et al., 2014) and rising population of BCS (Bray et al., 2018). 
Importantly, BCS have been shown to present with a chronic 
low- grade inflammatory status (e.g., elevated resting inter-
leukin- 6 and C- reactive protein) relative to healthy controls. 
Therefore, it could be plausible that any BCS- related reduc-
tions in thermoregulatory function may be coupled with aug-
mented inflammatory responses relative to age and body size/
composition- matched women following exercise completed 
in warm and hot conditions. Consequently, more focus is 
needed on the health and well- being of BCS and the impacts 
of physical activity and heat stress have on this population.
The current study aimed to assess how BCS respond in 
terms of their thermoregulation, inflammatory, and perceptual 
responses to moderate exercise under heat stress compared to 
females without cancer, serving as non- cancer comparators, 
well matched for age and biophysical characteristics. It was 
hypothesized that (1) BCS would experience greater thermal 
strain during moderate exercise under heat stress, (2) BCS 
would demonstrate a reduced functional capacity in hot condi-
tions, and (3) there would be higher baseline and change post- 
exercise in inflammatory markers in BCS compared to controls.
2 |  METHOD
2.1 | Participants
Twenty- one (9 BCS (age; 52 ± 7 years, stature; 167 ± 5 cm, 
body mass; 68.7 ± 8.5 kg, and body fat; 32.1% ± 3.9%), 12 
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controls [CON] (age; 56 ± 7 years, stature; 167 ± 6 cm, body 
mass; 67.7 ± 7.3 kg, body fat; 30.0% ± 3.7%)) females were 
volunteered for this study. All were physically active to the 
extent that they self- reported they were able to complete the 
recommended World Health Organization (WHO) guide-
lines of physical activity (Bull et al., 2020), this was not as-
sessed via activity monitors. Ethical approval was obtained 
from the University of Brighton Research Ethics Board 
(2019- 0365- Relf), conforming to the principles outlined in 
the Declaration of Helsinki, 2013, except for registration 
in a database. All participants provided written and verbal 
informed consent before any preliminary or experimental 
trials. Participants were excluded if they had prior or were 
currently being treated for, respiratory or cardiovascular ill-
nesses or were taking medication that affected thermoregula-
tion. Participants had not experienced hot air temperatures 
(>25℃) for >3  months, were post- menopausal, and were 
non- smokers. BCS had additional inclusion criteria; females 
age <65 years, first- time diagnosis of cancer, no other can-
cer, considered disease- free at the time of study enrollment, 
and at least 4 weeks past completion of the surgery, radia-
tion, or chemotherapy (Table 1). If the women were taking 
tamoxifen, they were required to have been taking the drug 
for at least 6 weeks (Carpenter, Elam, et al., 2004). The aver-
age quantity and severity (1– 10 scale) of hot flashes per day 
experienced by each BCS were obtained (Table 1).
2.2 | Experimental design
Participants completed one screening session and two experi-
mental blocks, with each block requiring two laboratory vis-
its (five visits in total). During the initial screening session, 
and after informed consent was provided, stature (Detecto), 
body mass (Adam Equipment Inc.), and body fat percentage 
were determined from the measurement of skinfold thick-
ness at four sites (Durnin & Womersley, 1974; Siri, 1956). 
Thereafter, participants completed a two visit experimental 
block representative of the mean climate during the UK sum-
mer months (both sessions at 25℃, 50% relative humidity 
[RH]), and a two visit block representative of the peak cli-
mate during the UK summer months (both sessions at 35℃, 
50% RH) (Waldock et al., 2018). The order of the 25 or 35℃ 
experimental blocks was randomized via a Latin square de-
sign, and all visits were separated by ~7 days. During the first 
visit of each block (week 1), participants completed a sub-
maximal exercise test (in either 25 or 35℃) to determine the 
exercise intensity (4 metabolic equivalents [METS]) for the 
subsequent main experimental trial, which was completed 
~7 days later under the same environmental conditions. All 
participants completed both experimental blocks and all ex-
perimental testing was completed in an environmental cham-
ber (TISS).
2.3 | Standardization of diet and 
physical activity
Participants were required to abstain from caffeine and alco-
hol (Shirreffs & Maughan, 2006) 12 h before each session, 
and to avoid exhaustive exercise (Stewart et al., 2014) for 
24  h before trials. Participants were requested to consume 
similar diets in the 24  h before each trial, with adherence 
confirmed verbally with participants before each trial (but 
not formally assessed via diaries). All experimental trials 
were conducted between 1600 and 1900, to coincide with en-
hanced viability of sweat output in females (Relf et al., 2019) 
and the previously identified peak in hot flash occurrence 
(Freedman, 2014). Participants were required to arrive in a 
euhydrated state and provide a fresh, mid- flow urine sample, 
with hydration status assessed via urine- specific gravity and 
urine osmolality following established criteria (Sawka et al., 
2007). During each trial, participants wore shorts and a t- shirt 
and were not permitted to drink until the final blood sample 
was drawn.
2.4 | Submaximal exercise testing
After verbal confirmation that trial standardization had been 
adhered to, participants were instrumented in a room (~22℃) 
before completing a 21- min submaximal test. The test con-
sisted of seven stages, which began at 3.5 km·hr−1 and in-
creased every 3 min by 0.5 km·hr−1, at 1% gradient (Jones 
& Doust, 1996) on a treadmill (WoodwayPRO, Woodway 
GmbH). At 2 min into each stage, ~45 s of expired air was 
collected using open- circuit spirometry. Gas samples col-
lected were analyzed using a gas analyzer (Servomex Xentra 
4100, Servomex International Ltd, and Buhler Gas Sample 
Dryer, Type PKE4, Buhler Technologies GmbH). Gas tem-
perature and volume were sampled using a fixed flow pump 
(model Dymax 30, Charles Austin Pumps Ltd.) and dry gas 
meter (Harvard Apparatus Ltd). Once analyzed, MET cal-
culation for each stage was acquired and from regression, 
each equation was used to prescribe the correct intensity for 
the main trial. After a short rest period, participants were fa-
miliarized with the 6- minute walk test (6MWT; described 
below) to reduce learning effects (Laskin et al., 2007). This 
familiarization process was completed in both preliminary 
trials (25 and 35℃) before each of the main trials.
2.5 | Main experimental trials
After verbal confirmation of before- trial standardization (via 
verbal questioning), and measurement of hydration status as 
previously described, nude body mass (NBM) was measured 
to the nearest 0.01 kg using digital scales (Adam, GFK 150) 
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and participants were instrumented in ambient laboratory con-
ditions (22.3 ± 1.1℃, 32.3 ± 2.5% RH). After instrumenta-
tion and 10 min of seated rest, a venous blood sample (~10 ml) 
was collected from the antecubital fossa. Participants then en-
tered the environmental chamber set to either 25℃/50% RH 
or 35℃/50% RH and completed a further 30  min of seated 
rest. At the end of the rest period, participants moved to the 
treadmill and completed an exercise protocol designed to align 
with the WHO guidelines of physical activity (Bull et al., 2020) 
(30- minute walk at a moderate exercise intensity, 4 METS). 
Immediately after the 30- minute walk, functional capacity was 
assessed via a 6MWT ([Relf et al., 2019; Waldock et al., 2018]; 
Figure 1), a test shown to be valid and reliable for distance cov-
ered on a treadmill (Laskin et al., 2007). When the participant 
had indicated their readiness to start, the experimenter increased 
the treadmill speed to 3 km·h−1. Participants then self- reported 
if they wanted the speed increased or reduced. Core tempera-
ture (Tre), heart rate (HR), ratings of perceived exertion (RPE), 
thermal sensation (TS), local thermal sensation (LTS), thermal 
comfort (TC), distance covered (m), and end speed (km·hr−1) 
were recorded at the cessation of the 6MWT. All participants 
were given the same instructions throughout the test.
2.6 | Instrumentation and measurements
Tre was monitored throughout all trials using a single- use rec-
tal probe (449H, Henleys Medical), self- inserted 10 cm past 
the anal sphincter. Skin temperature was recorded using skin 
thermistors (Eltek Ltd) attached to four sites; the midpoint of 
the right pectoralis major, the midpoint of the right triceps bra-
chii lateral head, right rectus femoris, and right gastrocnemius 
lateral head. Thermistors were connected to a temperature log-
ger (Squirrel 1000 series, Eltek Ltd.) and mean skin tempera-
ture (Tskin) was calculated using the equation by Ramanathan 
(1964). A HR monitor (Polar FT1, Polar Electro) was affixed 
to the chest. HR, Tskin, and Tre were taken at rest and 5- min 
intervals throughout trials, and HR and Tre were also recorded 
at the end of the 6MWT. Expired air was collected at three 
time points during the 30- minute walk (min 4– 5, 14– 15, and 
24– 25) and analyzed as previously described to assess the ac-
curacy of the MET prescription and to calculate metabolic 
heat production (Cramer & Jay, 2019). Whole- body sweat rate 
(WBSR; non- urine fluid loss) was assessed via NBM taken 
before and after the trial and reported in L·hr−1. Local sweat 
rate (LSR) was assessed in real- time using the KuduSmart® 
wearable monitor and via Tegaderm (Tegaderm™ +Pad, 3 M 
Health Care) patches, which were placed on the dorsal surface 
of three sites (lower back, chest, and forearm) and standardized 
for all participants (Relf et al., 2019).
2.7 | Subjective ratings
Participants were familiarized with perceptual scales dur-
ing the submaximal exercise testing visits. RPE (6 = Very, 
very light to 20  =  Maximal exertion) (Borg, 1982; Toner 
et al., 1986), TS, LTS (0 Unbearably cold to +8 Unbearably 
hot) (Toner et al., 1986), and TC (1 = Very comfortable to 
6  =  Very uncomfortable) (Guéritée & Tipton, 2015) were 
taken at 10- min intervals during the main experimental trials, 
and at the end of the 6MWT.
2.8 | Blood sampling and analysis
Following 10 min of seated rest in ambient temperature before 
and after the main trials, a 10 ml of venepuncture sample was 
collected from the antecubital fossa. Blood was transferred 
into two 5 ml tubes (EDTA Sarstedt, Aktiengesellschaft and 
Co) and centrifuged (Eppendorf 5702 R Centrifuge) for 10- 
min at 4500 revs·min−1. Plasma was aliquoted into 1.5  ml 
microtubes and stored at −86℃ until analysis. Commercially 
available ELISA kits were used to measure Interleukin- 6 (IL- 
6), IL- 10, C- reactive protein (CRP), Transforming growth 
factor- beta (TGF- β1), and Interferon- gamma (IFN- γ) in du-
plicate (Quantikine ELISA kits, R&D Systems). Inter- plate 
coefficients of variation were 7% (IL6), 7% (IL10), 10% 
(CRP), 4% (TGF- β1), and 8% (IFN- γ). We were unable to 
gain samples from one participant due to collapsed veins and 
F I G U R E  1  Outline and timings of 
each of the experimental protocol, where; 
6MWT, 6- minute walk test; HR, heart 
rate; LTS, local thermal sensation; METs, 
metabolic equivalents; RPE, ratings of 
perceived exertion; SR, sweat rate; TC, 
thermal comfort; Tre, core temperature; 
TS, thermal sensation; Tskin, mean skin 
temperature
6 of 16 |   RELF Et aL.
discomfort from chemotherapy, therefore, n = 8 for the BCS 
group is reported. One participant was below the lower limit 
of detection (LOD) for resting IL- 10, and another participant 
was below the LOD for resting IFN- γ. To account for the 
missing data points, the lower limit of detection divided by 
two (LOD/2) was used (LaFleur et al., 2011).
2.9 | Statistical analyses
Power analysis (G*Power, Version 3.1.5) was conducted 
using an α- level of p < 0.05, pre- defined minimal clinically 
important differences (MCID) between groups for physi-
ological variables, and a moderate effect size (ƞp
2 = 0.06). A 
total of 18 participants (9 per group) would result in an 84% 
probability (i.e., 1−β) of detecting a group−condition inter-
action for rectal temperature (MCID = 0.20℃) and heart rate 
(MCID = 5 beats·min−1), and an 82% probability for detect-
ing a group−condition interaction for whole- body sweat rate 
(MCID = 0.2 L·min−1). These degrees of change were set due 
to previous literature determining them as sufficient indica-
tors of heat adaptation (Willmott et al., 2015).
All physiological, perceptual, and inflammatory data were 
analyzed using jamovi (version 1.6.7). Data are reported as 
mean ± SD, with alpha set at p ≤ 0.05. Before analysis, data 
were tested for normality and sphericity using the Shapiro– 
Wilk test. Variables collected at single time points (baseline 
urine- specific gravity, urine osmolality, body mass, 6MWT 
distance, sweat measures, and fold change in cytokines) were 
compared between the BCS and CON groups using a two- way 
mixed- model analysis of variance (ANOVA) with the factors of 
temperature repeated (two levels; 25 and 35℃) and group (non- 
repeated, BCS and CON). Three- way mixed- model ANOVAs 
with the factors of time (repeated at seven levels for Tre, HR, 
Tskin; four levels for RPE, TS, LTS, and TC; two levels for in-
flammatory markers), condition (two levels: 25 and 35℃), and 
group (two levels: BCS and CON) were employed to evaluate 
the responses at rest and during and after exercise. When an 
interaction or main effect was observed, post hoc comparisons 
were made using the Tukey's HSD test. For all significant main 
effects and interactions, effect sizes were calculated as partial 
eta squared (ƞp
2) to provide an objective indication of the mag-
nitude of difference. For reference, values of 0.01, 0.09, and 0.25 
are considered small, medium, and large effects (Lakens, 2013).
3 |  RESULTS
3.1 | Participant characteristics and equality 
of study conditions
Mean participant characteristics, hydration status, exercise 
intensity, metabolic heat production, and ambient conditions 
are presented in Table 2. The CON and BCS groups were 
not different in age, stature, body mass, body surface area, 
or body fat percentage. Both groups were similarly hydrated 
before each main trial, as indicated by osmolality and urine- 
specific gravity values. There were no differences in exercise 
intensity, metabolic heat production, or environmental condi-
tions noted between groups or conditions (Table 2).
3.2 | Cardiovascular responses
Prior to the start of the 4 MET walk, resting HR was elevated 
by ~8 beats·min−1 in 35℃ compared to 25℃ (effect of con-
dition, p < 0.0001, ƞp
2 = 0.92), though there was no condi-
tion × group interaction (p = 0.23, ƞp
2 = 0.07; Figure 2a). 
Thereafter, HR responses exhibited a time × condition inter-
action (p = 0.023, ƞp
2 = 0.12) whereby HR was elevated by 
~12 beats·min−1 at each time point throughout the 35℃ con-
dition compared to 25℃. When expressed as the change in 
HR from the first resting measurement to the end of exercise, 
a main effect for condition (p = 0.0019, ƞp
2 = 0.41), and a con-
dition × group interaction was found (p = 0.02, ƞp
2 = 0.25; 
Figure 2b). Post hoc analysis revealed that the change in 
HR was not different between the 25 and 35℃ conditions 
for CON (~4 beats·min−1 difference; p = 0.84). In contrast, 
a ~20 beats·min−1 difference was observed between the 25 
and 35℃ conditions in the BCS group (p = 0.004), equating 
to a ~12 beats·min−1 difference from CON. However, after 
correction for multiple comparisons, the difference between 
groups was not statistically different (p = 0.11).
3.3 | Thermoregulation
There was a main effect for condition (p  =  0.00008, 
ƞp
2 = 0.57), time (p < 0.00001, ƞp
2 = 0.871), and a condi-
tion × time interaction (p < 0.00001, ƞp
2 = 0.556) for rec-
tal temperature (Figure 2c). Post hoc analysis revealed that 
Tre was not elevated during the 30- min rest period for either 
condition, and was therefore similar prior to the start of the 
4  MET walk for both CON (25℃: 37.16  ±  0.31℃, 35℃: 
37.24  ±  0.22℃) and BCS (25℃: 37.04  ±  0.22℃, 35℃: 
37.25 ± 0.28℃; condition × group interaction: p = 0.822). 
During exercise in the 35℃ condition, Tre was elevated from 
rest from 10 min of exercise onwards (p < 0.001), and from 
20 min onwards in the 25℃ condition (p < 0.0001). Rectal 
temperature was higher in the 35℃ versus 25℃ condition 
after 10 min of exercise and remained ~0.3– 0.4℃ higher at 
each time point. A similar response was observed between 
CON and BCS groups (condition  ×  time  ×  group interac-
tion, p = 0.19). When expressed as change from rest, there 
was a main effect for condition (p = 0.00002, ƞp
2 = 0.627), 
such that the change in Tre was ~0.25℃ greater in the 35℃ 
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compared to 25℃ condition (p = 0.0002), with this change 
being similar between the CON and BCS groups (condition 
by group interaction, p = 0.245; Figure 2d).
There was a main effect for condition (p  <  0.00001, 
ƞp
2  =  0.967), time (p  <  0.00001, ƞp
2  =  0.820), and a con-
dition ×  time interaction (p < 0.00001, ƞp
2 = 0.433) for Tskin 
(Figure 2e). Post hoc analysis revealed that Tskin was elevated 
from 5 min of rest in the 35℃ condition and throughout each 
remaining time point, with no difference observed between 
CON and BCS groups (condition × time × group interaction, 
p = 0.952).
WBSR was ~0.4 L·hr−1 greater after the 35℃ trial com-
pared to the 25℃ trial (main effect of condition, p < 0.00001, 
ƞp
2 = 0.837; Figure 2f). Although the condition × group interac-
tion did not meet conventional levels of statistical significance 
(p = 0.084, ƞp
2 = 0.149), visual inspection of the data revealed 
that one BCS participant recorded a WBSR ~0.40  L·min−1 
greater than the group mean after the 35℃ condition (1.1 vs. 
0.70 L·hr−1 BCS group mean, clear circle in Figure 2f).
All measurements of localized sweat rate were elevated 
in the 35℃ trials relative to the 25℃ trial (main effects for 
condition all p < 0.05, Table 3), and no differences between 
the CON or BCS groups were found (condition × group in-
teraction all p > 0.05).
3.4 | Functional performance
There was a main effect for condition (p < 0.0036, ƞp
2 = 0.377) 
and group (p = 0.036, ƞp
2 = 0.210), but no condition × group 
interaction (p = 0.683, ƞp
2 = 0.009) for distance covered in 
the 6MWT. Both groups covered a greater distance in the 
25℃ versus 35℃ (by ~200 m; p = 0.003). In addition, the 
control group covered more distance than BCS, regardless of 
environmental temperature (by ~400 m, p = 0.03; Figure 3).
3.5 | Perceptual responses
RPE, TC, TS, and LTS all increased throughout the exercise 
(main effect of time, p < 0.001, ƞp
2 = 0.802), and were higher 
in the 35℃ versus 25℃ conditions (main effect condition) 
T A B L E  2  Baseline standardization of physical anthropometrics, activity, and temperatures prior to the 25 and 35℃ conditions for BCS (n = 9) 
and CON (n = 12)




Urine BCS Osmolality 
(mOsm·kg−1)
149 ± 99 138 ± 86 0.648, 0.011 0.513, 0.023
CON 232 ± 169 293 ± 228
BCS Urine- specific gravity 1.003 ± 0.003 1.008 ± 0.16 0.327, 0.050 0.485, 0.026
CON 1.006 ± 0.006 1.007 ± 0.007
Exercise intensity BCS Average METs 4.01 ± 0.33 4.16 ± 0.29 0.855, 0.002 0.444, 0.031
CON 4.16 ± 0.29 4.10 ± 0.28
Ḣprod
BCS Absolute (W) 251 ± 31 258 ± 31 0.107, 0.131 0.606, 0.014
CON 248 ± 32 252 ± 24
BCS Relative (W·kg−1) 3.71 ± 0.24 3.81 ± 0.13 0.096, 0.139 0.744, 0.006
CON 3.67 ± 0.17 3.75 ± 0.19




BCS Humidity (%) 50.81 ± 0.81 49.61 ± 1.02 0.073, 0.159 0.462, 0.029
CON 51.6 ± 1.26 51.08 ± 2.31
Category Variable BCS CON
p 
value
Anthropometrics Age (years) 52 ± 7 56 ± 7 0.437
Stature (cm) 167 ± 5 167 ± 6 0.438
Body mass (kg) 68.70 ± 8.50 67.73 ± 7.25 0.910
Body surface area 1.77 ± 0.12 1.76 ± 0.11 0.953
Body fat (%) 32.1 ± 3.9 30.0 ± 3.7 0.074
Oxygen consumption Average VO2 (ml·kg−1·min−1) 10.04 ± 1.58 9.21 ± 1.53 0.236
Data are shown as mean ± SD. Exercise intensity and Ḣprod were calculated from an average of three gas samples taken over the 30 min of exercise.
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F I G U R E  2  HR (a, b), Trec (c, d), and Tskin (e) responses of CONT and BCS throughout rest, 30 min of exercise, and following the 6MWT in 
25 and 35℃ conditions. Panels on the left display the mean and SD at each time point, and panels on the right display each change (lines) from 
rest to the end of the 30- min exercise bout. Box plots display the median (mid- line), mean (cross), and the 25 and 75th interquartile ranges (boxes), 
and whiskers illustrate the highest and lowest values. Panel (f) displays WBSR responses for the CONT and BCS groups after exercise in the 25℃ 
(white boxes) and 35℃ (gray boxes) conditions. Where; *different from rest (p < 0.05), #different between 25 and 35℃ (p < 0.05), ǂdifferent 
between BCS and CON (p < 0.05)
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for both experimental groups (group−condition × time inter-
action, p < 0.001, ƞp
2 = 0.823), as demonstrated in Table 4.
3.6 | Inflammatory responses
Absolute concentrations for all inflammatory measurements, 
the ANOVA interaction, and effect size are presented in Table 
5. Resting cytokine concentrations were not different between 
groups (all p > 0.20). Expressed as a change from rest, IL- 6 
was increased by ~0.75 pg·ml−1 after exercise (main effect of 
time, p = 0.0002, ƞp
2 = 0.536), regardless of condition (main 
effect of condition = 0.194) or group (p = 0.96). In contrast, 
IL- 10 was unchanged after exercise in the 25℃ condition, 
but increased by ~1.8  pg·ml−1 after exercise in the 35℃ 
condition (main effect of condition, p = 0.034, ƞp
2 = 0.226), 
and was similar between groups (p  =  0.82). The resulting 
IL6/IL10 ratio was higher after exercise in 25 versus 35℃ 
(by ~0.6; main effect for condition, p = 0.016, ƞp
2 = 0.279), 
which was not different between groups (p = 0.86). IFN- γ 
concentrations increased by ~0.82  pg·ml−1 after exercise 
(main effect of time, p  =  0.035, ƞp
2  =  0.235), regardless 
of condition (main effect of condition, p = 0.327) or group 
(p  =  0.794). CRP was increased after exercise in both the 
25℃ (by ~0.37 mg·L−1) and 35℃ (by ~0.29 mg·L−1) condi-
tion for the BCS, and only increased following the 35℃ con-
dition in CON (by ~0.14 mg·L−1). After exercise, CRP was 
~0.39 mg·L−1 higher in the BCS versus CON (group effect, 
p = 0.0002) regardless of condition. TGF- β1 was unchanged 
from rest in either condition (p = 0.525) and was not shown 
to be different between groups (p = 0.459).
4 |  DISCUSSION
This study aimed to examine whether breast cancer survi-
vors differ in thermoregulatory, perceptual, and inflamma-
tory responses at rest, during, and after moderate exercise in 
warm (25℃) and hot (35℃) conditions compared to a care-
fully matched control population. The principal findings of 
this study are: (1) when exercising according to the current 
WHO- prescribed guidelines (30  min of moderate exercise; 
~4 METS) (Bull et al., 2020), thermoregulatory function, 
perceptions of effort, thermal comfort, and thermal sensation 
were similar between age- matched controls and BCS in both 
warm and hot conditions; (2) functional exercise performance 
assessed, using a validated 6- minute walk test, was impaired 
in BCS regardless of the temperature the test was completed 
in; (3) of the markers of systemic inflammation measured, 
only CRP was shown to be different between experimental 
groups and was ~0.33 mg·L−1 higher after exercise in BCS 
versus controls, regardless of environmental temperature, 
which is not enough to alter risk category for cardiovascular 
T A B L E  3  Whole- body sweat rate and local sweat rate measures during the 25 and 35℃ conditions for BCS (n = 9) and CON (n =  12)
25℃ trial 35℃ trial Main effects
BCS CON BCS CON Condition Group
WBSR (L·hr−1) 0.37 ± 0.11 0.34 ± 0.18 0.70 ± 0.20 0.81 ± 0.18 <0.00001 0.51
LSR (mg·min−1·cm−2)
Back 0.23 ± 0.16 0.25 ± 0.19 1.08 ± 0.61 1.31 ± 0.41 <0.00001 0.35*
Chest 0.14 ± 0.08 0.12 ± 0.08 1.16 ± 1.04 1.16 ± 0.55 0.00001 0.96*
Upper arm 0.06 ± 0.05 0.05 ± 0.04 0.25 ± 0.14 0.27 ± 0.13 <0.00001 0.83
Forearm 0.07 ± 0.08 0.08 ± 0.08 0.35 ± 0.14 0.46 ± 0.18 <0.00002 0.19
KuduSmart 0.44 ± 0.20 0.38 ± 0.09 1.27 ± 0.30 1.33 ± 0.32 <0.00003 0.98*
Data are shown as mean ± SD.
*Indicates non- parametric statistics.
F I G U R E  3  Mean and individual participant data points between 
BCS (n = 9) and CON (n = 12) for the end distance in the 6MWT for 
both temperature conditions. Box plots display the median (mid- line), 
mean (cross), and the 25 and 75th interquartile ranges (boxes), and 
whiskers illustrate the highest and lowest values. Lines represent each 
individual participant performance in the 25℃ (white boxes) and 35℃ 
(gray boxes) conditions
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disease in adults (Pearson et al., 2003). No differences at rest 
or following exercise were noted for IL- 6, IL- 10, IFN- γ, and 
TGF- β1. Overall, the data from this study provides evidence 
that thermoregulation, perceptions of temperature sensation/
comfort, and the after- exercise inflammatory responses in 
warm and hot conditions are not compromised in BCS when 
compared to control participants well matched for biophysi-
cal characteristics. Despite no differences in physiological 
or perceptual responses versus healthy controls, BCS self- 
selected a lower work intensity during the functional capacity 
6MWT which led to reduced distances regardless of environ-
mental condition and is suggestive of some degree of func-
tional impairment.
To the best of our knowledge, this is the first study that ex-
amines the thermoregulatory responses of BCS during both 
warm and hot environmental conditions. We incorporated 
an exercise duration and intensity derived from the current 
WHO guidelines for physical activity and previous research 
in our laboratory for vulnerable populations (Waldock et al., 
2018), which allowed us to investigate the physiological re-
sponses to this novel cohort under conditions they could be 
realistically expected to experience throughout the summer 
months. Importantly, our control and BCS groups were care-
fully matched for age and biophysical characteristics– – key 
methodological considerations that can reduce potential bias 
when exploring thermoregulation between two independent 
groups (Cramer & Jay, 2015). We aimed to recruit BCS that 
self- reported symptoms that are indicative of vasomotor 
impairments, with 8/9 of our cohort reporting regular hot 
flashes (compared to 1/12 in the control group). By ensur-
ing our BCS experienced hot flashes, we ensured our experi-
ment would be able to explore the anticipated reduced/altered 
thermoneutral zone (Freedman, 2014) in BCS compared to 
matched controls.
Our original hypothesis, that BCS who suffer from symp-
toms indicative of impaired vasomotor function (e.g., hot 
flashes and night sweats), may also display impaired ther-
moregulation, is not supported by our data. Both exper-
imental groups exercised at the same relative and absolute 
rate of metabolic heat production during each condition 
(~3.7 W·kg−1/~250 W), and consequently, we observed simi-
lar Tre responses throughout rest and during exercise between 
groups (Figure 2c,d). We acknowledge that changes in body 
heat content are underestimated when determined by ther-
mometry (e.g., changes in rectal temperature) when com-
pared to direct calorimetry, thus any reduction in the ability 
of BCS to dissipate heat may not always be reflected in the 
measurements of core body temperature. Although we en-
sured a constant thermal drive (i.e., a metabolic heat produc-
tion of 3.7 W·kg−1, Table 2) in both experimental cohorts, 
the levels of heat strain and acute nature of our study may not 
have been of sufficient intensity or duration to identify dif-
ferences in thermoregulatory responses between groups, with 
moderate ∆Tre of 0.3– 0.5℃ in 25℃ and 0.6– 0.7℃ in 35℃ 
observed. We completed all experimental testing between 
1600 and 1900  h– a period previously associated with the 
natural circadian peak for hot flashes in menopausal women 
(Carpenter et al., 2002, 2012). However, no participant in ei-
ther group reported any symptoms before, during, or after the 
experimental trials. It is plausible that the occurrence of hot 
flashes may display a different circadian rhythm in those re-
covering from breast cancer compared to menopausal women 
(Carpenter et al., 2002; Freedman, 2014). Our data suggest 
that BCS can adhere to present physical activity guidelines 
without the risk of increased negative side effects associated 
with impaired vasomotor responsiveness. Our study specifi-
cally addresses a brief (~70 min) acute exposure– – responses 
over consecutive days or more prolonged exposures to heat 
stress, such as those encountered during a heatwave event re-
quires further research.
Heart rate was assessed to examine the interactive effect 
of environmental temperature and disease state on the car-
diovascular strain. When expressed as a change from resting 
HR, the control population shows greater cardiac stability, 
with only ~10  beats·min−1 (range: −10  ±  23  beats·min−1) 
difference between the end of exercise at 25℃ and the com-
mensurate time point at 35℃. In contrast, a ~20 beats·min−1 
(range: 7 ± 46 beats·min−1) difference between 25 and 35℃ 
conditions was observed for BCS (Figure 2b). Although the 
interaction did not reach conventional levels of statistical sig-
nificance (p = 0.11), potential between- group differences in 
cardiovascular responses warrant some brief consideration 
as the difference between conditions is ~4- fold higher than 
our pre- determined minimum clinically important difference 
(5 beats·min−1). During exercise in the heat, HR is increased 
in line with skin temperature to support the greater skin blood 
flow requirement that attends a narrowing core- skin thermal 
gradient. Given that both core and skin temperatures were not 
different between groups, and that both dry and evaporative 
heat loss responses were also similar between groups, it is 
unlikely that ~12 beats·min−1 difference in final HR observed 
between the 35℃ condition can be attributed solely to thermo-
regulatory impairments. One potential explanation is a clin-
ically significant cardiac dysfunction induced after exposure 
to anthracyclines, a class of chemotherapeutics (Curigliano 
et al., 2010). In the present study, participants who under-
went treatment with anthracyclines (n = 6) had heart rates 
of 5– 10  beats·min−1  higher at all time points in the 25℃ 
condition, and ~7– 10 beats·min−1 higher at all time points in 
35℃ condition compared to BCS who did not undergo this 
treatment (n = 3), demonstrating a degree of cardiac instabil-
ity. Further emphasized by absolute HR’s indicating greater 
cardiovascular strain post 30- min exercise between groups in 
35℃ (BCS vs. CON; 131 ± 14 vs. 119 ± 8 beats·min−1). We 
employed a widespread non- categorizing approach during 
recruitment, allowing all types of BCS to be enrolled in the 
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study. As a result, our sample includes an array of; treatment 
types, medication, length post- treatment, and diagnosis, and 
so we cannot make firm inferences regarding treatment types 
and effects to physiological function, and particularly the ef-
fects of anthracyclines on cardiac function. Research specif-
ically investigating thermal/physiological responses in BCS 
treated with anthracyclines and/or other treatment modalities 
is warranted because it is feasible that these variations may 
impact physiological responses.
Interestingly, BCS self- selected a lower work intensity 
during both environmental temperatures compared to con-
trols, and as a consequent completed ~400 m less distance, 
irrespective of similar aerobic fitness observed in prelimi-
nary tests (Table 2). This is less than the error for a tread-
mill 6MWT for current data (typical error of measurement: 
2.1%– 4.6% [13– 29 m] between groups), and previous litera-
ture in varying populations (5.2% [23 m] (Olper et al., 2011) 
and when performed over- ground (4.2% [16.6 m] (Sandberg 
et al., 2020). The reduction in physical performance appears 
to have occurred independently from physiological cues 
(e.g., skin temperature) known to influence pacing behaviors 
(Schlader et al., 2011; Tucker et al., 2006). Consistent with 
our physiological observations, no between- group differences 
for perceptions of effort were observed in either environmen-
tal condition during the 30- min steady- state walking. Despite 
some evidence that BCS experienced elevated cardiovascular 
strain during 35℃, both groups displayed similar RPE values 
(13 ± 3 and 13 ± 2), equating to a verbal queue of “somewhat 
hard.” To establish if perceptions of thermal sensation had 
been affected due to breast cancer diagnosis and treatment, 
we examined localized thermal sensation to the chest region 
(LTS). LTS values followed an identical pattern to overall TS, 
rising throughout the exercise, and higher in 35 versus 25℃. 
No differences were noted for eccrine sweating, specific to 
the chest region (Table 3), suggesting that the local sweat rate 
in this specific body region (chest) and thermal sensation is 
not affected after BC treatment. We are unable to provide a 
clear reason for the reduction in functional performance, but 
suggest that this could also be related to treatment- induced 
impairments in cardiovascular function in a subset of our 
BCS population.
Associations between small, prolonged increases in 
plasma inflammatory cytokines and chemokines, and per-
sistent fatigue have been reported in cancer survivors (Bower 
& Lamkin, 2013)– – a population already characterized by 
reductions in physical activity levels (Littman et al., 2010). 
Although there is some evidence which suggests inflamma-
tory markers are elevated in BCS when compared to healthy 
women (Seruga et al., 2008), many studies are not well 
controlled for lifestyle factors known to influence the mea-
surement of systemic cytokines (e.g., pre- sampling physical 
activity levels, no or poorly reported dietary control, lack of 
control for circadian variation, and different sampling times), 
and are also confounded by clinical factors which alter sys-
temic inflammatory measurements, limiting interpretation. 
In the present study, we use two experimental groups, well 
matched for both age and physical characteristics, and im-
plemented well- controlled pre- trial standardization protocols 
regarding diet, physical activity, and circadian variation. We 
show that both the control and BCS groups had resting IL- 6 
concentrations (~1.5– 4.5  pg·ml−1) well within the healthy 
range reported for middle- aged adults (Ridker et al., 2000). 
Resting IL- 6 in BCS was similar to concentrations reported in 
the Yale Exercise and Survivorship study (~1.9– 3.6 pg·ml−1) 
(Jones et al., 2013) and far below concentrations previously 
reported in some BCS cohorts (19.7 ± 41.2 pg·ml−1) (Rogers 
et al., 2013) and 16.3 ± 25.9 pg·ml−1 (Gómez et al., 2011). 
Resting IL- 10, IFN- γ, TGF- β1, and CRP were also sim-
ilar between our experimental groups at rest, and reflective 
of normative concentrations reported in the wider literature 
for older populations, regardless of disease state (Kim et al., 
2011). Discrepancies between studies are difficult to reconcile 
and could reflect simple population differences; differences 
in body composition– with increased adiposity known to ele-
vate inflammatory markers (Pudkasam et al., 2017); a range 
of years after diagnosis; and type and sensitivity of assays 
utilized– with older multiplex assays known to be less sensi-
tive than ELISAs available at the time (Gómez et al., 2011).
In the present study, the similar thermal, cardiovascular 
and perceptual strain responses observed between the con-
trols and BCS were paralleled by similar between- group cy-
tokine responses in the period immediately after exercise, 
regardless of environmental temperature. Given that the 
participants in the current study were physically active in 
daily living (although not trained), and physical exercise pro-
grams have been shown to reduce inflammatory responses 
in both healthy populations and those recovering from BC 
(Meneses- Echavez et al.,; Mills, 2017; Petersen & Pedersen, 
2005), it would be of interest to examine the systemic cy-
tokine responses to exercise in warm and hot conditions in 
more sedentary or less healthy BCS, and make compari-
sons to similarly well- matched controls. It remains unknown 
whether more prolonged or repeated exercise periods in the 
heat exacerbates the inflammation or cytokine response and 
symptoms associated with such disorders, potentially putting 
less healthy BCS at increased risk of heat- related injuries, ill-
nesses, or health complications during prolonged heat wave 
events.
4.1 | Perspectives
Breast cancer survivors report negative side effects (e.g., fa-
tigue and hot flashes) and lack knowledge and confidence re-
garding safety of physical activity (Pekmezi et al., 2012), all 
of which are possible contributors to the reported 30%– 47% 
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of the BCS population not achieving the recommended daily 
activity guidelines (Casla et al., 2014). A chronic low- grade 
inflammatory state has also been suggested to impact physi-
cal activity behaviors and sensations of fatigue and is also 
known to alter thermoregulatory control. Although specula-
tive, we suggest that BCS may have self- selected a slower 
pace as a form of anticipatory behavioral thermoregulation 
based upon previous experiences of vasomotor symptoms 
(HFs), acting pre- emptively to ensure excessive heat accu-
mulation does not occur via a reduction in exercise intensity 
before any sensory physiological signals (e.g., increased Tre) 
are initiated (Tucker et al., 2006).
Our study provides evidence that healthy BCS can achieve 
30  min of moderate exercise guidelines in both warm and 
hot conditions, without negative consequences or side effects 
usually attributed to this condition, and with no alterations 
in inflammatory status when compared to females with no 
history of breast cancer. The results of this study represent a 
starting point, in which further work investigating thermoreg-
ulatory and cardiovascular function during exposures with 
durations and intensities that are representative of those ex-
perienced during heatwaves is required. Establishing whether 
the results presented herein are applicable to physical activity 
performed across multiple days (i.e., 3 days per week physical 
activity guidelines, or more prolonged heatwave simulations) 
would enable the development of bespoke physical activity 
guidelines for this specific population and which can be tai-
lored toward reducing the negative consequences and side 
effects of both exercise and high environmental temperatures.
4.2 | Considerations
The present study was conducted at one exercise intensity 
and duration designed to reflect the current guidelines for 
daily physical activity. It is plausible that if the duration of 
exercise or the length of exposure to environmental heat had 
been longer, alterations in physiological function, or subjec-
tive reporting of symptoms such as hot flashes would become 
apparent. The population of BCS in the present study self- 
report as adhering to current physical activity guidelines, and 
likely represent healthy members of the BCS community, 
therefore, may mitigate any potential detrimental side ef-
fects. This is reinforced by BCS covering a greater distance 
than healthy individuals, of similar age, in previous litera-
ture (~300 m more) (Sperandio et al., 2015). Work in which 
less active and healthy BCS with chronic low- grade inflam-
mation undergo similar protocols is, therefore, necessary in 
order to better characterize the overall population, and de-
termine whether guidelines tailored toward mitigating health 
risks associated with exposure to heat need to be targeted/
adjusted for different members of the BCS community.
For methodological limitations, the MCIDs were estab-
lished from heat adaptation data in a healthy population 
(Willmott et al., 2015). It is acknowledged that utilizing these 
data may not hold the same validity as if from a clinical pop-
ulation; however, in the absence of bespoke clinical data in 
BCS, it was utilized as a foundation to establish meaningful 
differences between groups. Moreover, while the induction 
of hot flashes was not the focus of this paper, it would have 
been interesting and valuable to measure vasomotor function 
directly, therefore, future research should endeavor to include 
this in their design.
5 |  CONCLUSION
No compromise in any physiological, inflammatory, or per-
ceptual parameters was observed between BCS and controls 
before, during, and after exercise in both warm and hot con-
ditions. BCS self- selected a reduced work intensity during 
a test of functional capacity (6MWT) in both warm and hot 
conditions, without differences in measured physiological or 
perceptual markers. However, a heightened cardiovascular 
strain was highlighted in the data between populations and 
therefore may explain the reduced capacity to work. Further 
investigations into the impact of BC on the cardiovascular 
strain, especially those post- chemotherapy, are therefore 
warranted.
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